Peripheral T-cell lymphoma, not otherwise specified
MONDO:0004964Aggressive nodal or extranodal mature (peripheral) T-cell lymphomas that do not belong to the better defined entities of the remainder of mature T-cell lymphomas. This category includes the following variants: lymphoepithelioid cell variant (Lennert's lymphoma), follicular variant, and T-zone variant.
Also known as: peripheral T-cell lymphoma, not otherwise specified, PTCL
1954 clinical trials for this condition and its sub-types, 61 tagged with Peripheral T-cell lymphoma, not otherwise specified itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Lymphoma drug duvelisib tested after transplant – trial ends early
Disease control Stopped earlyThis phase 2 trial tested the drug duvelisib (Copiktra) as a maintenance therapy after an autologous stem cell transplant in 17 people with T-cell lymphoma. The goal was to see if it could safely delay the cancer from coming back. The study was terminated early, so the full resul…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Experimental CAR T-Cell therapy targets tough lymphoma
Disease control Stopped earlyThis early-phase trial tested a new treatment called AUTO4 for people with a type of T-cell lymphoma that had come back or not responded to prior therapy. AUTO4 is a CAR T-cell therapy designed to recognize and attack cancer cells carrying a specific marker called TRBC1. The stud…
Phase 1/2 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC